Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Tonix Pharmaceuticals Holding Corp. (TNXP) Addressing Underserved Therapeutic Indications with Three Ongoing Clinical Studies

Tonix Pharmaceuticals is a clinical-stage pharmaceutical company focused on the development of next-generation medications for disorders of the central nervous system. The company’s leading product candidate, Tonmya, is currently being evaluated in a phase III clinical study for the treatment of fibromyalgia, as well as a phase II clinical study for the treatment of post-traumatic stress disorder. Additionally, Tonix’s product pipeline includes TNX-201, which is currently being studied in a phase II proof-of-concept trial for the treatment of episodic tension-type headaches.

“Having three large, adequate and well-controlled clinical studies in high-value therapeutic indications simultaneously ongoing validates our business model of developing next generation medicines for significant unmet needs in a capital-efficient manner,” Dr. Seth Lederman, chairman and chief executive officer of Tonix, stated in a news release.

When commercialized for the treatment of fibromyalgia, Tonmya will give Tonix access to a large and relatively underserved market within the pharmaceutical industry. According to the Centers for Disease Control and Prevention, fibromyalgia affects an estimated five million Americans. Recent evidence suggests that poor sleep quality likely plays a fundamental role in the development and persistence of the disorder, which is characterized by chronic widespread pain and abnormal pain processing. Tonmya addresses this issue by performing as a low-dose sleep aid to improve quality of rest, effectively minimizing the effects of fibromyalgia symptoms. Top-line data from the company’s ongoing clinical study is expected in the second half of 2016.

In June, Tonix substantially increased its potential for short-term growth within the pharmaceutical industry by initiating its phase II study of TNX-201. Designed to establish efficacy and safety evidence to support future studies, the results of this trial could clear the way for the continued development of the first new prescription pharmaceutical approved to treat episodic tension-type headaches in more than 40 years.

“Approximately 75 million people in the U.S. suffer from frequent episodic tension-type headache, a condition that is estimated to be three times as prevalent as migraine,” continued Lederman. “If approved by the FDA, TNX-201 may become the only non-narcotic prescription medicine for episodic tension-type headache.”

Moving forward, Tonix’s promising product pipeline could provide a formidable platform for the company to realize tremendous market growth. For prospective shareholders, the company’s ongoing clinical trials and the immense market potential of its drug candidates combine to make Tonix an intriguing investment opportunity in the months to come.

For more information, visit

Posted in Small Cap News | Leave a comment

Sonus Networks, Inc. (SONS) Leveraging Innovative Technological Solutions to Increase Presence in Evolving Communications Industry

Sonus Networks enables and secures real-time communications that allow the world’s leading service providers and enterprises to embrace the next generation of session initiated protocol (SIP) and 4G/VoLTE solutions – including voice over IP (VoIP), video, instant messaging and online collaboration. With nearly two decades of industry experience, the company provides a complete portfolio of hardware-based and virtualized session border controllers (SBCs), diameter signaling controllers (DSCs), policy/routing servers and media and signaling gateways to customers in nearly 100 countries around the globe.

Since being founded in 1997, Sonus has increased its market presence by successfully evolving to meet the demands of the communications industry. In 2014, the company built on this proven strategy through the launch of its SBC 7000. Utilizing a transcoding firmware with nearly double the capacity of competitive systems, this purpose-built platform is capable of licensing up to 150,000 sessions for secure, reliable delivery of multimedia services in the world’s largest communications networks. Through the commercialization of this product, Sonus provides its clients with the means for streamlined expansion of operational capacity in order to effectively accommodate rapid customer growth.

“Service providers today are facing insatiable demand for multimedia communications applications – voice, video and data – and many of them are struggling with how to meet this demand,” David Tipping, vice president of Sonus, stated in a news release. “Sonus now offers a disruptive platform that resets service providers’ expectations for real-time dependent sessions with scale.”

This dedication to scale could pay dividends for Sonus in the future. According to a report by IBISWorld, VoIP has experienced massive growth over the past five years in both commercial and residential applications. From 2010 to 2015, the overall market recorded annual growth of 17.5 percent. Moving forward, increased network capacity will be essential, as the continued expansion of 4G data networks will likely propel accelerated adoption of real-time communication solutions in the years to come.

Despite recording mildly disappointing financial results in the first quarter of 2015, Sonus remains in a strong competitive position to capitalize on the inevitable technological shift of the communications industry. For prospective investors, the company’s persistent commitment to innovative technologies, along with its recent efforts to optimize its cost structure, could provide a platform to realize improved returns in the months ahead.

For more information, visit

Posted in Small Cap News | Leave a comment

Supertel Hospitality, Inc. (SPPR) Utilizing New Investment Strategy to Maximize Returns in Growing Hotel Industry

Supertel Hospitality is a self-administered real estate investment trust that specializes in the ownership of select-service hotels. The company currently owns 49 hotels in 19 states that are operated by various third-party management companies – including Hilton Hotels and Resorts® (HLT), Choice Hotels® (CHH) and Wyndham® Hotels (WYN) – through franchise agreements.

In recent months, Supertel has initiated a new investment strategy involving upper midscale and upscale hotels in order to maximize shareholder returns in the future. In the first quarter of 2015, the company announced the sale of four hotels around the country for a cumulative sum of $7.5 million. In the second quarter, the company sold three additional properties for $9.3 million, and seven other hotels were also listed for sale as of March 31, 2015. With this influx of capital, Supertel has taken steps toward improving its balance sheet by repaying underlying loans. Following associated debt repayments, these sales are expected to generate approximately $14.5 million in net proceeds, which should enable the company to more effectively adhere to its updated investment strategy.

“The company is actively seeking acquisitions as we expand the efforts to recycle capital into newer hotels with higher margins in sectors and markets with characteristics having the potential to create higher shareholder value,” Bill Blackham, chief executive officer of Supertel, stated in a news release. “As this effort is underway, the underlying hotel portfolio appears to be on track to deliver an increased contribution and that should help to accelerate growing the company during this time of transition.”

Despite its transitional efforts, Supertel has realized noteworthy financial growth from its portfolio of properties in recent months. The company’s first quarter revenue from continuing operations was $12.3 million, which was a 9.3 percent year-over-year increase. Likewise, Supertel’s revenue per available room (RevPAR) improved by 9.9 percent to $35.19 for the period, outperforming the growth of the national hotel industry by nearly two percent.

As the global economy continues to recover moving forward, the hotel industry is expected to experience strong growth. According to a report by Statista, revenue generated by the global hotel industry is expected to climb to $550 billion in 2016, representing a 20 percent improvement over the results of 2011. For Supertel, this industry growth should provide a strong platform to post improved financial results. For prospective investors, the company’s recent efforts to increase shareholder value could foreshadow an opportunity to realize strong returns in the years to come.

For more information, visit

Posted in Small Cap News | Leave a comment

Sino Mercury Acquisition Corp. (SMAC) Poised to Profit in SME & Microfinance amid Easing of Lending Regulations

It seems like the historic transformation of China’s loan-to-deposit ratio at hand, as a law that has been in place since 1995 mandating that lending be limited to 75 percent of deposits, has been put on the path to becoming a mere reference point rather than a regulatory statue. Following a State Council statement on June 24, which indicated a forthcoming proposal to amend the nation’s loan-to-deposit ratio law, the floodgate is now apparently opening to SME lending. As Chinese Premier Li Keqiang moves to get better handles on the massive state-run banking sector, which has some $29 trillion in assets (or nearly twice the size of the same sector in the U.S.), this move to rev up the country’s credit lending engine has already ignited a firestorm of activity among Chinese banking stocks.

The State Council decision to try and make it easier for banks looking to lend is a clear expression of the growth potential of the service sector in China, where the opportunities for small, private-sector businesses are now quite abundant. The unmistakably clear signal from the CBRC to boost lending to SMEs, in an effort to outstrip last year’s enormous, roughly $3.34 trillion in small business loans, is a strong response to overall economic growth slowing to 7.4 percent last year. While a 20-year low, this growth figure is still considerably higher than the 2.4 percent figure for the U.S. last year. We are looking at a primed environment in China for integrated lending solutions; a sector which could explode over the next several years, especially if growth in the overall Chinese economy continues to shrink slightly each year moving forward, showing how much infrastructural build-out has truly been accomplished.

A burgeoning Chinese SME sector, increasingly dotted by service entities and light industry, is an ideal environment for leading provider of integrated lending solutions, Sino Mercury Acquisition (NASDAQ: SMAC). Sino Mercury Acquisition, operating through the post-acquisition Wins Finance Holdings, Inc., which is worth around $168 million, continues primarily doing direct equipment leasing, as well as purchase-lease-back, and providing financial leasing, guarantee and advisory services to SME markets in Shanxi Province and the PRC capital, Beijing.

Wins Finance conducts its financial guarantee business through its wholly-owned Shanxi Dongsheng Financial Guarantee subsidiary and was one of the first batch of companies to receive the China Financial Guarantee Permit for Business. Right in the heart of the action, SMAC is busily facilitating SME financing through its guarantor activities, working with clients to craft customized financing plans that suit the size, scale and industry of a given SME, and securing the repayment of debts from any guaranteed borrowers that may default.

The small lending sector is so hot right now in China that even Amazon (NASDAQ: AMZN) rival, Alibaba (NYSE: BABA), is getting into the market via the recent launch of what is effectively the second online bank to go live in China this year with a premade audience, MYbank. MYbank directly connects Alibaba merchants and lenders, leveraging the credit and sales data available from Alibaba’s zero-fee, third-party online payment platform, AliPay, which has over 300 million users. With an army of over eight million vendors, bolstered by mostly small or micro sized operators, Alibaba’s Taobao Market has had a revolutionary impact on how customers and entrepreneurs are connected in real-time. SME lending for equipment keeps this market humming and that is one big reason a company like SMAC is poised to branch out and become a platform solution for markets well beyond the Shanxi region.

Sino Mercury Acquisition’s focus on SME lending makes SMAC well-poised to profit in such an environment as this, especially given the full range of individually-tailored consultancy services Wins Finance provides. By really getting to know the client’s business, financial condition and needs, as well as the requisite quantity and usage plans for the loan, Wins Finance is able to keep tight control over defaults and help maximize funding availability to SME clients at the same time. The company’s tireless dedication to being the tip of the spear in the SME space over the last several years has given Wins Finance a better smell for this market than other financial institutions like state-owned banks.

To further ensure success with each individual case, Wins Finance provides additional cash flow management, comprehensive financial planning, and tax savings advice. The financial leasing arm of Wins Finance is Jinshang International Financial Leasing, which has previously executed several big contracts in the healthcare, as well as energy and environment industries. The strong ties to regional banks and financial institutions developed since Jinshang International’s inception in 2009, culminating in such major contracts, has given this division of Wins Finance ample opportunity to hone a talent for financial product design and implementation as well.

China’s central bank put the figure for operating microcredit companies in the country last year at around 8.2k, up 36 percent since 2012. However, because only about 10 percent of these companies serve the widest financial inclusion possible and because they previously lacked greater incentives to really jump start lending, the sphere of less-profitable microlending has gone largely untapped.

The outlook is bright for SMAC and future plans for Wins Finance include a series of additional integrations and mergers designed to strengthen the company’s existing footprint, beefing up its asset management, as well as other financing operations, such as commercial factoring and microfinance. Commercial factoring for instance, which originated in the textile industry, is the selling of accounts receivable in order to lay hands on immediate capital, and the practice represents a kind of fluid debt-financing that is particularly attractive to many SMEs in China. According to analysis from November 2014 of the global microfinance sector, this year was projected as clocking in another impressive uptick of 15 to 20 percent growth (responsAbility Investments), with Asia in particular emerging center stage.

After many years putting together a first-class team of managers and really honing its long-term strategic approach to the SME lending sector, Wins Finance is now ready to make good use of the relationships it has established within the regional ecosystem of finance partners, government entities and SME customers. By being able to deliver a visionary, scalable, one-stop-shop solution that is designed to solve Chinese SME financing problems, the company has the potential to rapidly proliferate. A broad-spectrum platform approach to the space, including a diverse product mix and innovative modeling, will serve Wins Finance well as it continues to act as a much-needed bridge between banks and SME customers.

With well over 8.5k guarantee companies and 1.2k financing leasing companies currently in China, the market is obviously quite fragmented and thus, a scalable platform solution like the one Wins Finance has put together could become a disruptive adaptation, whose roll out just so happens to be perfectly timed to coincide with the prevailing easing of the loan-to-deposit ratio.

For more information on Sino Mercury’s Wins Finance acquisition, visit

Posted in Small Cap News | Leave a comment

Net Element, Inc. (NETE) Active in its Pursuit to Become Premier Mobile Payments and Transactional Services Provider

It’s been a busy week for technology innovator Net Element as the company issued a shareholder update, inclusive of the company’s recent financing of at least $10.5 million to sustain further expansion initiatives, as well news that its pending acquisition target has signed a contract to process transactions for several international dating networks.

Net Element leverages its core technology innovations and operational business partners to provide mobile payments and value-added transactional services in emerging countries and in the United States. To this accord, the company is continuously seeking out growth opportunities.

In its recent news release, Net Element defined its primary goal for the second half of 2015 as integrating PayOnline’s value-added technologies with Net Element’s current U.S. offerings to solidify its foothold as a premier payments-as-a-service company with a centralized, omni-channel global platform.

Upon closing of the acquisition, Net Element will be able to sell its mobile payment services to PayOnline’s more than 10 million active consumers and thousands of merchants in the Russian Federation, Europe and Asia.

“The acquisition of PayOnline will be transformative for the Company not only as a profitable acquisition but for the cutting edge payments tools it provides such as its recently announced availability of an online transactional platform for iOS apps (iPhone and iPad),” Net Element said in the news release.

PayOnline’s recent three-year contract centers on a minimum processing commitment of $300 million in transactions for social networks AnastasiaDate, AmoLatina and AsianDate, among others. Net Element currently manages, operates and is in the process of integrating the PayOnline group of companies pending closing of Net Element’s acquisition of the company.

The acquisition will add to Net Element’s current portfolio of subsidiaries, which include TOT Group, Inc., a global mobile payments and transaction processing provider whose companies include Unified Payments, Aptito and TOT Money, and emphasizes Net Element’s ability to facilitate cross-border transactions through a single interface.

“This contract win demonstrates our ability to quickly derive value from strategic acquisitions and partnerships,” Net Element CEO Oleg Firer stated in the news release. “As we emerge from a period of financial and business restructuring, we plan to see more such value driving developments as we progress into our growth phase.”

The financial restructuring mentioned by Firer, along with other achievements and the pending acquisition of PayOnline, triggered a reiterated 12-month price target of $5.17 per share by SeeThruEquity.

“Net Element has achieved several important developments since our last update in March 2015. Most importantly, Net Element made substantial progress shedding cumbersome debt on its balance sheet and announced a new $24.5mn capital raise. While improving its financial position, the company also reported double-digit annual growth in both 1Q15 and fiscal 2014 results and announced several growth initiatives for 2015 and beyond. The company also announced that it had executed definitive documentation for the acquisition of PayOnline, a leader in online transaction processing services and payment technology with over 10mn active consumers and thousands of merchants in the Russian Federation, Europe and Asia. We are reiterating our 12 month price target on NETE of $5.17 per share,” stated SeeThruEquity CEO Ajay Tandon.

Net Element is quick on its feet in taking advantage of opportunities that add momentum to grow revenues, by attracting more merchants to its payments platform, contributing to its overarching mission to become a competitive leader in mobile payments and transactional services in target countries and the United States.

For more information visit

Posted in Small Cap News | Leave a comment

Bollente Companies, Inc. (BOLC) Looks to Capitalize on More Stringent Energy Regulations through Expansion of trutankless® Brand

Bollente Companies, Inc. (OTCQB: BOLC), through its trutankless® brand, is a manufacturer and distributor of innovative tankless water heaters in the United States. The company strives to create electric tankless water heaters that far surpass traditional tank water heaters in terms of energy efficiency, output, dependability and environmental sustainability while effectively overcoming the drawbacks of lesser tankless units.

In April, Bollente announced the release of a new line of water heaters geared toward budget-driven customers. These products, known as the Vero™ line, boast the same unrivaled water heating performance, durability and space savings of the trutankless flagship line at a fraction of the cost. Following the enactment of updates to the National Appliance Energy Conservation Act earlier this year, Bollente expects this new product line to provide an opportunity for sustainable market growth in the future.

“The new Department of Energy guidelines for water heaters are going to impact the majority of homes that currently use traditional tank water heaters,” Michael Stebbins, president of trutankless, stated in a news release. “Tanks will become larger and costlier to install, and homes requiring tank heaters that hold 55 or more gallons will have to upgrade to a heat pump for twice the cost, or go tankless. We are pleased to offer whole-home electric tankless solutions that already exceed the new energy factor guidelines.”

The company’s product offerings also include truCirc, a state-of-the-art water circulation pump designed to work seamlessly with its efficient water heaters. truCirc allows users to accurately track water usage throughout their homes and predict when hot water will be needed. By learning usage patterns, the device limits energy usage by keeping water hot only when it is likely to be needed. The product’s intuitive interface also allows homeowners to quickly and easily change delivery modes and zones to minimize wasted water.

“As a standalone product, truCirc provides tremendous energy and water savings for a household,” continued Stebbins. “When used in conjunction with a 99 percent energy-efficient trutankless unit, the end result is a complete water heating system with unrivaled efficiency, durability and long-term value to the homeowner.”

As the home construction industry continues to shift toward more environmentally-friendly solutions, Bollente is in a strong strategic position to record improved financial results. According to a report by McGraw Hill Construction, the overall green single-family housing market is expected to account for more than $80 billion in revenue by 2016, representing a 100 percent increase over the results of 2013. This continued market growth could provide Bollente with an opportunity to post strong results in the future.

Bollente’s proven product line provides the company with a platform to realize continued growth in the months to come. For prospective investors, this growth could translate into sustainable returns moving forward.

For more information, visit

Posted in Small Cap News | Leave a comment

Keryx Biopharmaceuticals, Inc. (KERX) Posts Strong Financial Results following Commercial Launch of Auryxia™

Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that provide unique and meaningful advantages to patients with renal disease. In December 2014, the company launched its first FDA-approved product, Auryxia™, in the United States for the treatment of elevated serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis. Keryx’s novel treatment is also being commercialized in Japan as Riona® for the treatment of patients with all stages of CKD by the company’s Japanese partner.

According to the National Kidney Foundation, approximately 26 million Americans currently suffer from kidney disease. Among those individuals, approximately 450,000 people are on dialysis treatments. For these people, maintaining serum phosphorus levels is imperative. An additional report by the National Kidney Foundation states that prolonged exposure to elevated phosphorus levels has been shown to cause increases in calcium-phosphate production, which is commonly associated with increased morbidity and, in many cases, mortality. This data highlights the immense market potential of Auryxia moving forward.

In the first quarter of 2015, Keryx leveraged the marketability of its groundbreaking product to record promising financial results. The company reported total revenue of approximately $1.2 million, including both U.S. product revenue and license revenue associated with sales of Riona in Japan. These figures are expected to rise in the future. In June, Keryx announced that Auryxia had been added to the Medicare Part D formularies of two national insurance providers, giving the company access to approximately 65 percent of people in the United States currently taking phosphate binders.

“The inclusion of Auryxia on the major insurance providers’ Part D formularies, which we expect will start processing claims in the third quarter, significantly expands unrestricted access to Auryxia for people on dialysis and their caregivers,” Greg Madison, chief executive officer of Keryx, stated in a news release. “Looking ahead, we are focused on continuing to raise awareness of Auryxia’s clinical profile among the prescribing community and ensuring that the vast majority of dialysis patients have access to this important medicine.”

In addition to plans of adding a team of field sales representatives in the months to come, the company’s short-term objectives include expanding the indication for Auryxia to include the treatment of iron deficiency anemia in patients with CKD. In September 2014, Keryx initiated a phase III study for this indication which is expected to be completed by the end of 2015.

For more information, visit

Posted in Small Cap News | Leave a comment

Feel Empowered to Make that Trade with

Purchasing stock confidently requires the right knowledge. As Francis Bacon, the father of the scientific method once stated, “Knowledge is power.”

In mankind’s agricultural past, ownership of land and property meant power. During the Industrial Revolution, ownership of factories and machinery became the basis of wealth and power. Now more than ever, in our globally integrated cybernetic information driven world, knowledge and information in and of itself has become the basis of wealth and power. Examples of those that are powerful due to our current knowledge based society include the wealth of Bill Gates to the influence of the large pharmaceutical companies of which both are based on intellectual property rights.

Control of information is something corporate elites always recognized as a way to consolidate and build wealth and power. In 1983, 90% of American media was owned by 50 companies. Right now, over 90% of the information diet of 313 million Americans is controlled by 6 corporations: News Corporation, Disney, Comcast, Viacom, Time Warner, and CBS. That is 90% of everything Americans see, hear, and consider important. As author Tom Clancy pointed out, those that control the information can control the people. Governments that are despotic have long recognized the importance of controlling the flow of information in a society. For example, China’s government controls its population in part by maintaining massive surveillance and a content control system over their population’s access to the Internet. As elites and governments recognize the importance of controlling knowledge and information, so should you be seeking to build on your sources of information.

Decisions do not happen in a vacuum. They are best made when the individual has sufficient information to weigh the possible consequences of various choices. Access to the right information gives decision-making power, builds your range of options from which to make choices, and is a key step toward empowerment and building wealth. Knowledge gives competence and the capacity to act, and sets one on a path of never ending and self-initiated growth.

One of’s primary goals is to help investors make the right decisions and discover undervalued stocks poised for exceptional profits. For more information, visit

Posted in Small Cap News | Leave a comment

ENGlobal Corporation (ENG) – Committed to Value

For three decades, ENGlobal has strived to become the preferred supplier of innovative engineering and automation solutions to a string of global clients. The company has aimed high with the intention of becoming the number one provider of novel automation integration services and select engineering, procurement, and construction management projects for the energy industry and other markets around the world.

In the time since its establishment in the 1980s, ENGlobal has become well-known. Today, the company is recognized as a specialty engineering services firm that focuses on serving a variety of markets from alternative energy, pulp and paper and government clients to the upstream, midstream and downstream sectors.

ENGlobal stakes its reputation on the consistent delivery of superior, value-added products and services that meet its commitment to quality. The company also closely follows the ISO-9001 standards that guide its industry to ensure it constantly delivers the best possible value for all stakeholders. Additionally, the team members at ENGlobal hold tightly to quality. It is one of six core values that govern the company’s operations, as seen below:

1. Safety first
2. Communication from the start
3. Teamwork in everything
4. Quality throughout
5. Ethics without exception
6. Total responsiveness

A Houston, Texas-based company, ENGlobal focuses on automation solutions and select engineering, procurement, and construction management projects. The company operates through these two business segments: automation and engineering. The automation segment offers integrated services linked to designing, fabricating and implementing advanced automation, distributed control, instrumentation and process analytical systems – and its solutions fall under two categories: integration and engineering. The EPCM segment provides consulting services for the development, management and execution of projects requiring professional engineering, construction management, and related support services.

For more information, visit

Posted in ENGlobal Corp. ENG | Leave a comment

Synergy Pharmaceuticals, Inc. (SGYP) Preparing to File New Drug Application for Leading Product Candidate

Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) is a biopharmaceutical company focused on the development of novel therapies to treat gastrointestinal diseases and disorders. The company’s product pipeline includes two drug candidates currently being studied in four unique indications. Synergy’s leading candidate, plecanatide, is in late-stage clinical trials for the treatment of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). Additionally, the company’s next-generation candidate, SP-333, has successfully completed a phase II study in patients with opioid-induced constipation (OIC) and is currently being studied for the treatment of ulcerative colitis (UC).

In recent weeks, Synergy has made noteworthy progress toward the eventual commercialization of plecanatide. Earlier this month, the company announced the initiation of its second phase III clinical trial evaluating the efficacy and safety of the drug candidate in treating IBS-C. Synergy also recently announced positive top-line data results from its first of two phase III trials evaluating the treatment in patients with CIC. According to a report by the National Institute of Health, CIC affects an estimated 14 percent of the global population, demonstrating the immense market potential of plecanatide. Moving forward, these figures could translate into an opportunity for Synergy to experience improved financial results.

“These results strengthen our belief that plecanatide has the potential to not only effectively treat constipation but with a durability and tolerability profile that is ideal for chronic use,” Dr. Gary S. Jacob, chairman and chief executive officer of Synergy, stated in a news release. “We look forward to the results of our second pivotal [CIC] trial in the coming weeks.”

In the first quarter of 2015, Synergy secured the necessary capital to move forward in developing its promising product pipeline. Through a sale of common stock, the company added $5.4 million in net cash to its existing resources. As of March 31, 2015, Synergy’s cash and cash equivalents amounted to approximately $178.6 million, which will allow the company to continue vital clinical testing in the months to come.

“[This] is a pivotal year for Synergy and I am confident we are well-positioned to achieve our clinical objectives,” continued Jacob. “[We] will remain focused on advancing these programs, as well as filing our first NDA (new drug application) with plecanatide for CIC by year-end.”

By providing an effective treatment option for CIC, the company will be able to address an underserved market within the pharmaceutical industry. For prospective investors, Synergy’s rapid approach toward the commercialization of its leading drug candidate could foreshadow an opportunity for favorable returns in the months to come.

For more information, visit

Posted in Small Cap News | Leave a comment